DK1414414T3 - Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet - Google Patents

Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet

Info

Publication number
DK1414414T3
DK1414414T3 DK02754615T DK02754615T DK1414414T3 DK 1414414 T3 DK1414414 T3 DK 1414414T3 DK 02754615 T DK02754615 T DK 02754615T DK 02754615 T DK02754615 T DK 02754615T DK 1414414 T3 DK1414414 T3 DK 1414414T3
Authority
DK
Denmark
Prior art keywords
water
cross
drug
charged
insoluble drugs
Prior art date
Application number
DK02754615T
Other languages
English (en)
Inventor
Massimo Bresciani
Lorenzo Magarotto
Luca Dobetti
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1414414T3 publication Critical patent/DK1414414T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
DK02754615T 2001-06-29 2002-06-03 Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet DK1414414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20010628 2001-06-29
PCT/EP2002/006052 WO2003002097A1 (en) 2001-06-29 2002-06-03 Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers

Publications (1)

Publication Number Publication Date
DK1414414T3 true DK1414414T3 (da) 2008-03-03

Family

ID=11042810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754615T DK1414414T3 (da) 2001-06-29 2002-06-03 Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet

Country Status (11)

Country Link
US (1) US8889182B2 (da)
EP (1) EP1414414B1 (da)
JP (1) JP2005503360A (da)
AT (1) ATE377413T1 (da)
AU (1) AU2002321061B2 (da)
CA (1) CA2452575C (da)
DE (1) DE60223382T2 (da)
DK (1) DK1414414T3 (da)
ES (1) ES2295379T3 (da)
NZ (1) NZ530826A (da)
WO (1) WO2003002097A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
ES2380318T3 (es) * 2002-04-12 2012-05-10 Alkermes Pharma Ireland Limited Formulaciones nanoparticulares de megestrol
BRPI0412263B1 (pt) 2003-07-22 2019-10-15 Arena Pharmaceuticals, Inc. Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição
JP2007535774A (ja) * 2004-04-30 2007-12-06 ヒルクレスト・ラボラトリーズ・インコーポレイテッド 自由空間ポインティングデバイスにおける意図的でない動きを除去するための方法およびデバイス
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
JP5393677B2 (ja) 2007-08-15 2014-01-22 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−HT2Aセロトニン受容体に関連した障害の治療のための5−HT2Aセロトニン受容体のモジュレーターとしてのイミダゾ[1,2−a]ピリジン誘導体
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
CN102083418A (zh) * 2008-04-24 2011-06-01 伊万斯彻有限公司 口服避孕药剂及其制备方法
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CN102264354B (zh) 2008-10-28 2015-03-25 艾尼纳制药公司 用于治疗5-ht2a5-羟色胺受体相关障碍的5-ht2a5-羟色胺受体调节剂组合物
ITMI20120092A1 (it) * 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
US10034859B2 (en) 2015-07-15 2018-07-31 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2634004B2 (de) 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
DE3320583A1 (de) 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
IT1298574B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione

Also Published As

Publication number Publication date
AU2002321061B2 (en) 2006-08-24
EP1414414A1 (en) 2004-05-06
US20040213840A1 (en) 2004-10-28
JP2005503360A (ja) 2005-02-03
WO2003002097A1 (en) 2003-01-09
ATE377413T1 (de) 2007-11-15
ES2295379T3 (es) 2008-04-16
NZ530826A (en) 2004-09-24
CA2452575C (en) 2010-11-02
CA2452575A1 (en) 2003-01-09
DE60223382D1 (de) 2007-12-20
EP1414414B1 (en) 2007-11-07
DE60223382T2 (de) 2008-09-11
US8889182B2 (en) 2014-11-18

Similar Documents

Publication Publication Date Title
DK1414414T3 (da) Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
DE60312482D1 (de) Oligomere kettenverlängerer zur behandlung und nachbehandlung sowie dem recycling von kondensationspolymeren, darauf basierende zusammensetzungen und anwendungen derselben
MX2009002653A (es) Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular".
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
DE69903351D1 (de) Vernetzte hyaluronsäure und ihre medizinischen verwendungen
WO1995011912A3 (en) Biopolymer synthesis utilizing surface activated, organic polymers
DK0910412T3 (da) Hydrolyserbare hydrogeler til kontrolleret frigørelse
ATE469179T1 (de) Hydrogel
ATA7692003A (de) Vernetztes, ultra-hochmolekulares polyethylen (uhmw-pe)
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
DK0914095T3 (da) Fremgangsmåde til fremstilling af polymerbaseret præparat til kontrolleret frigivelse
PT846184E (pt) Extraccao por solvente de polihidroxialcanoatos a partir de biomassa facilitada pela utilizacao de um nao solvente marginal para o pha
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
ATE520419T1 (de) Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels
DK1061948T3 (da) Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf
ITRM20020529A1 (it) Polimeri sterilizzanti, processo di loro preparazione ed uso.
DE69833487D1 (de) Polymer-wirkstoff-konjugate zur behandlung von krebs
DE50211023D1 (de) Enzymatische synthese von zuckeracrylaten
WO2003063824A3 (en) Pharmaceutical composition
WO2002004544A3 (en) Polymers and polymerization processes
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
BR0314984A (pt) Processo para a produção de formas de dosagem sólidas
DK1263413T3 (da) Fremgangsmåde til fremstilling af faste dispersioner
AU4068201A (en) Process for the preparation of accelerated release formulations using compressedfluids